RESUMEN
Iodolipids have been used as a contrast medium for hepatosplenic computed tomography (CT) in 148 patients. In all but two of these cases, the contrast material was injected by the intravenous route. The method appears to be safe due to the marked reduction of dosage in CT compared with conventional radiographic iodolipid hepatography. This decreased dosage is made possible by the improved density and spatial resolution of CT. Pictorial and histographic densitometric analysis of normal and abnormal liver after iodolipid administration yields considerable diagnostic improvement.
Asunto(s)
Yodo , Aceite Yodado , Lípidos , Hepatopatías/diagnóstico por imagen , Enfermedades del Bazo/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Ácidos Grasos , Humanos , Inyecciones Intravenosas , Lípidos/administración & dosificación , Hígado/diagnóstico por imagen , Neoplasias Hepáticas/diagnóstico por imagen , Polietilenglicoles , Bazo/diagnóstico por imagenAsunto(s)
Aceite Yodado , Hepatopatías/diagnóstico por imagen , Hígado/diagnóstico por imagen , Adulto , Estudios de Evaluación como Asunto , Femenino , Hepatomegalia/diagnóstico por imagen , Humanos , Inyecciones Intraarteriales , Inyecciones Intravenosas , Aceite Yodado/administración & dosificación , Masculino , Persona de Mediana Edad , RadiografíaRESUMEN
Hepatosplenography with intravenously injected iodized lipid emulsion has been performed in 30 cases and the results reported. The side effects were minor and transient, as the elimination is rapid. The uptake in the liver was satisfactory and permitted tomography both of the liver and the spleen. Small neoplasms and splenic nodules in Hodgkin's disease could be detected and located accurately.